MedTrace Logo

Multiple Micronutrient Versus Iron-Folic Acid Supplementation in Pregnant Women in Indonesia

NCT07725549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-07-24

No results posted yet for this study

Summary

Micronutrient deficiencies during pregnancy may affect the mother's nutritional status and the baby's growth. This study compared two types of daily supplements for pregnant women: a multiple micronutrient supplement and an iron and folic acid supplement.

Pregnant women in Indonesia who were at 12 weeks of gestation or earlier were randomly assigned to receive one of the two supplements for eight weeks. The study measured maternal body weight, mid-upper arm circumference, hemoglobin concentration, and serum zinc concentration before and after supplementation. Infant birth weight and the occurrence of low birth weight were assessed after delivery.

The purpose of the study was to determine whether multiple micronutrient supplementation produced greater improvements in maternal nutritional indicators and birth outcomes than iron and folic acid supplementation.

Conditions

Interventions

DIETARY_SUPPLEMENT

Multiple micronutrient supplementation

One tablet was administered orally once daily for eight weeks.

DIETARY_SUPPLEMENT

Iron and Folic Acid Supplementation

One tablet was administered orally once daily for eight weeks.

Sponsors & Collaborators

  • Indonesia Timur University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-10
Primary Completion
2025-12-25
Completion
2026-04-10

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07725549 on ClinicalTrials.gov